Additional Details
-
Phase 2 Clinical Trial of MNKD-201 (Nintedanib Dry Powder Inhalation) in Patients With Idiopathic Pulmonary Fibrosis
Trial Management Group IncWindsor ON. N8X1T3View Details -
Idiopathic Pulmonary Fibrosis (IPF)-Related Chronic Cough Reduction With Nalbuphine Extended-Release (NAL ER) Tablets
Critical Care Pulmonary and Sleep Associates (Ccpsa) - West ClinicLakewood CO. 80228View Details -
Idiopathic Pulmonary Fibrosis (IPF)-Related Chronic Cough Reduction With Nalbuphine Extended-Release (NAL ER) Tablets
Meris Clinical ResearchBrandon FL. 33511View Details -
Idiopathic Pulmonary Fibrosis (IPF)-Related Chronic Cough Reduction With Nalbuphine Extended-Release (NAL ER) Tablets
Newportnativemd, Inc.Newport Beach CA. 92663-3600View Details -
Idiopathic Pulmonary Fibrosis (IPF)-Related Chronic Cough Reduction With Nalbuphine Extended-Release (NAL ER) Tablets
Hannibal Regional HospitalHannibal MO. 63401View Details -
Idiopathic Pulmonary Fibrosis (IPF)-Related Chronic Cough Reduction With Nalbuphine Extended-Release (NAL ER) Tablets
Coastal Pulmonary & Critical Care, PLCSt. Petersburg FL. 33704-2733View Details -
Idiopathic Pulmonary Fibrosis (IPF)-Related Chronic Cough Reduction With Nalbuphine Extended-Release (NAL ER) Tablets
Palmtree Clinical ResearchPalm Springs CA. 92262View Details -
Idiopathic Pulmonary Fibrosis (IPF)-Related Chronic Cough Reduction With Nalbuphine Extended-Release (NAL ER) Tablets
Paradigm Clinical Research Centers, Inc. - ReddingRedding CA. 96001View Details -
Idiopathic Pulmonary Fibrosis (IPF)-Related Chronic Cough Reduction With Nalbuphine Extended-Release (NAL ER) Tablets
Anmed Medical CenterAnderson SC. 29621View Details -
Idiopathic Pulmonary Fibrosis (IPF)-Related Chronic Cough Reduction With Nalbuphine Extended-Release (NAL ER) Tablets
Clinical Research Associates of Central, PA, LLCDuBois PA. 15801View Details -
Idiopathic Pulmonary Fibrosis (IPF)-Related Chronic Cough Reduction With Nalbuphine Extended-Release (NAL ER) Tablets
Horizon Clinical Research GroupCypress TX. 77429View Details -
Idiopathic Pulmonary Fibrosis (IPF)-Related Chronic Cough Reduction With Nalbuphine Extended-Release (NAL ER) Tablets
Pulmonary Specialists of The Palm BeachesLoxahatchee Groves FL. 33470View Details -
Idiopathic Pulmonary Fibrosis (IPF)-Related Chronic Cough Reduction With Nalbuphine Extended-Release (NAL ER) Tablets
Clinical Research of Gastonia (CRG)Gastonia NC. 28054View Details -
Idiopathic Pulmonary Fibrosis (IPF)-Related Chronic Cough Reduction With Nalbuphine Extended-Release (NAL ER) Tablets
Elevate Clinical ResearchHouston TX. 77058View Details -
Idiopathic Pulmonary Fibrosis (IPF)-Related Chronic Cough Reduction With Nalbuphine Extended-Release (NAL ER) Tablets
El Paso Pulmonary Association, PAEl Paso TX. 79902View Details -
Idiopathic Pulmonary Fibrosis (IPF)-Related Chronic Cough Reduction With Nalbuphine Extended-Release (NAL ER) Tablets
Clinical Research and Associates, Inc.Miami FL. 33126View Details -
Advanced Imaging to Assess the Effect of Immunosuppression on Progressive Fibrosis
Massachusetts General HospitalBoston MA. 02114View Details -
Titrated Ambulatory Oxygen in Fibrotic ILD and COPD With Isolated Exertional Hypoxemia
State University of New York at Buffalo Jacobs School of Medicine and Biomedical SciencesBuffalo NY. 14203View Details -
Fibrotic Disease Activity in Cardiopulmonary Disorders Using 18F-Fibroblast Activation Protein Inhibitor (18F-FAPI-74) PET/CT Imaging
National Institutes of Health Clinical CenterBethesda MD. 20892View Details -
The ARGiNAUT study is testing AZD8965 in adults with idiopathic pulmonary fibrosis who may or may not be taking treatments to reduce the buildup of scar tissue in the lungs.
Banner Health University of ArizonaPhoenix AZ. 85006View Details